Drug stocks, fortified by hopes of bigger US sales, lifted European shares on Friday to end the week flat, though still near their best levels of the year.
The FTSE Eurotop 300 index ended the day up 0.5 percent at 939.91 points, with more than two shares rising for each one falling.
The benchmark struggled to match this year's peak set last week as Wall Street trading was mixed, but is up 10.5 percent for the year after its hefty rally from a six-year nadir in March.
"The market is no longer as good value as it was. Although we have a lot of headwind behind it with economic data coming up nicely, we have had several months in a row of good performance and I would not be surprised to see a pause," said Richard Champion of Pavilion Asset Management.
Among the standouts, ING Groep fell 1.4 percent to 18.6 euros as the Dutch firm, Europe's number three insurer, offered cautious guidance after reporting a weaker than expected third-quarter net operating profit.
Italian bank Capitalia reported forecast-beating quarterly numbers, sending its shares higher.
Parmalat ended the week down 12 percent on concerns about the Italian food group's balance sheet, sinking further on Friday on news its finance director had resigned.
Autos lagged as new car sales in western Europe slipped last month, and a dip in US retail sales last month was blamed on weaker demand. Europe's biggest carmaker Volkswagen said it would cut investment over the next five years, and its stock eased a touch to 44.9 euros.
The DJ Euro Stoxx 50 index, a benchmark of euro zone blue chips, closed up 0.8 percent at 2,656.9 points, while the FTSE 100 in London clocked up its best close since late August last year after hitting fresh yearly highs.
The construction sector benefited from signs of a European and Japanese economic recovery, hitting new highs for the year.
Glass maker Saint-Gobain rose three percent, while cement makers Lafarge, Holcim and Heidelbergercement all rose two percent or more.
"We are having a bit more rotation into what has underperformed, like some of the cyclicals. People are scouting around for what has not been involved in the rally," Champion said.
The DJ Stoxx health index hit yearly high on hopes reform of the US Medicare program for seniors would boost demand for prescription medicines in the world's biggest market.
"Investors are getting more confident that there will be a Medicare drug benefit passed in the near term," said Marc Booty, pharmaceuticals analyst at Commerzbank.
Pavilion Asset Management's Champion said it was too early to call a turn in the healthcare sector.
French drug firm Aventis SA rose 5.8 percent, while Britain's GlaxoSmithKline Plc tacked on 2.4 percent. Swiss Novartis AG rallied 3.7 percent, while Anglo-Swedish AstraZeneca gained 2.8 percent.
The Eurotop 300 index is only some six points from its yearly high set a week ago, underpinned by third-quarter earnings, the best since the start of 2000, and further signs of recovery.
Eurostat data on Friday confirmed the euro zone economy grew at 0.4 percent in the third quarter, its fastest rate in a year, and should pick up even more steam in the next six months.
Data on Friday showed a strong improvement in the University of Michigan index of US consumer confidence, and a surprise rise in producer prices.
After investors pushed stocks to new highs, there remained nagging doubts about the rally's sustainability, said Anais Faraj, strategist at Nomura.
"We remain positive, though acknowledge the rough terrain," Faraj added.
JP Morgan investment bank said global growth was supporting European equities and, at this point in the economic cycle, equities usually outperform bonds as earnings grow while bond yields see little lift, thus reducing pressure on a stock's valuation multiple.
In New York, as bourses shut the Dow Jones Industrial Average was flat at 9,846 points, while the NASDAQ Composite had shed 0.6 percent to 1,956 points.
BUSINESS UPDATE: The iPhone assembler said operations outlook is expected to show quarter-on-quarter and year-on-year growth for the second quarter Hon Hai Precision Industry Co (鴻海精密) yesterday reported strong growth in sales last month, potentially raising expectations for iPhone sales while artificial intelligence (AI)-related business booms. The company, which assembles the majority of Apple Inc’s smartphones, reported a 19.03 percent rise in monthly sales to NT$510.9 billion (US$15.78 billion), from NT$429.22 billion in the same period last year. On a monthly basis, sales rose 14.16 percent, it said. The company in a statement said that last month’s revenue was a record-breaking April performance. Hon Hai, known also as Foxconn Technology Group (富士康科技集團), assembles most iPhones, but the company is diversifying its business to
ARTIFICIAL INTELLIGENCE: The chipmaker last month raised its capital spending by 28 percent for this year to NT$32 billion from a previous estimate of NT$25 billion Contract chipmaker Powerchip Semiconductor Manufacturing Corp (力積電子) yesterday launched a new 12-inch fab, tapping into advanced chip-on-wafer-on-substrate (CoWoS) packaging technology to support rising demand for artificial intelligence (AI) devices. Powerchip is to offer interposers, one of three parts in CoWoS packaging technology, with shipments scheduled for the second half of this year, Powerchip chairman Frank Huang (黃崇仁) told reporters on the sidelines of a fab inauguration ceremony in the Tongluo Science Park (銅鑼科學園區) in Miaoli County yesterday. “We are working with customers to supply CoWoS-related business, utilizing part of this new fab’s capacity,” Huang said, adding that Powerchip intended to bridge
Microsoft Corp yesterday said that it would create Thailand’s first data center region to boost cloud and artificial intelligence (AI) infrastructure, promising AI training to more than 100,000 people to develop tech. Bangkok is a key economic player in Southeast Asia, but it has lagged behind Indonesia and Singapore when it comes to the tech industry. Thailand has an “incredible opportunity to build a digital-first, AI-powered future,” Microsoft chairman and chief executive officer Satya Nadella said at an event in Bangkok. Data center regions are physical locations that store computing infrastructure, allowing secure and reliable access to cloud platforms. The global embrace of AI
Qualcomm Inc, the world’s biggest seller of smartphone processors, gave an upbeat forecast for sales and profit in the current period, suggesting demand for handsets is increasing after a two-year slump. Revenue in the three months ended in June will be US$8.8 billion to US$9.6 billion, the company said in a statement Wednesday. Excluding certain items, earnings will be US$2.15 to US$2.35 a share. Analysts had projected sales of US$9.08 billion and earnings of US$2.16 a share. The outlook signals that the smartphone market has begun to bounce back, tracking with Qualcomm’s forecast that demand would gradually recover this year. The San